Management

Sol-Gel management includes industry veterans as well as leading scientists in the fields of dermatology, pharmaceuticals and microencapsulation. Years of applied experience, and deep cross-functional expertise equips Sol-Gel with unique qualities and capabilities.

Mr. Moshe (Mori) Arkin
Chairman

Mr. Moshe Arkin has served as chairman of our board of directors since 2014. Mr. Moshe Arkin currently sits on the board of directors of several health care companies including Exalenz Bioscience Ltd. (TASE:EXEN), a developer of advanced systems for gastrointestinal and liver disorders since 2006, Quiet Therapeutics Ltd., a cancer drug discovery and development and SoniVie Ltd., a private company developing systems for the treatment of pulmonary arterial hypertension. From 2005 to 2008, Mr. Arkin served as the head of generics at Perrigo Company (NYSE:PRGO; TASE:PRGO) and from 2005 until 2011 as the vice chairman of its board of directors. Prior to joining us, Mr. Arkin served as a director of cCAM Biotherapeutics Ltd., a company focused on the discovery and development of novel immunotherapies to treat cancer from 2012 until its acquisition in 2015 by Merck & Co., Inc. (NYSE:MRK). Mr. Moshe Arkin served as chairman of Agis Industries Ltd. from its inception in 1972 until its acquisition by Perrigo Company in 2005. Mr. Moshe Arkin holds a B.A. in psychology from the Tel Aviv University, Israel.

Mr. Alon Seri-Levy
Co-Founder and Chief Executive Officer

Mr. Alon Seri-Levy co-founded Sol-Gel and has served as our chief executive officer since our inception in 1997 and as a member of our board of directors until 2014. Prior to founding Sol-Gel, Mr. Seri-Levy established the computer-aided drug design department at Peptor Ltd., an Israeli research and development company specialized in the development of peptide-based drug products. Mr. Seri-Levy holds a Ph.D. in Chemistry (summa cum laude) from The Hebrew University of Jerusalem, Israel, and conducted his post-doctoral studies at Oxford University, United Kingdom.

Mr. Gilad Mamlok
Chief Financial Officer

Mr. Gilad Mamlok has served as our chief financial officer since March 2017. From August 2015 to January 2017, Mr. Mamlok served as the chief financial officer for Medigus Ltd., a medical device company dual listed on Nasdaq and the Tel Aviv Stock Exchange (“TASE”). From September 2005 to March 2015, Mr. Mamlok served as Senior Vice President, Global Finance and Accounting of Given Imaging Ltd., a medical device company dual listed on Nasdaq and TASE acquired by Covidien plc in February 2014. From January 2002 to September 2005, Mr. Mamlok served as chief financial officer of two other medical device companies. Mr. Mamlok holds a Master’s degree in Business Economics from Tel-Aviv University and a B.A. in Economics (magna cum laude) from Tel-Aviv University.

Mr. Ofer Toledano
VP Research and Development

Mr. Ofer Toledano has served as our vice president of research and development since 2004. Prior to joining Sol-Gel, Mr. Toledano served as manager of the formulation department at ADAMA Agricultural Solutions Ltd. (formerly known as Makhteshim Agan Industries Ltd.), an Israeli manufacturer and distributor of crop protection products from 1998 until 2004. Mr. Toledano holds a Ph.D. in chemistry from The Hebrew University of Jerusalem, Israel.

Ms. Ofra Levy-Hacham
VP Quality Assurance and Regulatory Affairs

Ms. Ofra Levy-Hacham has served as our vice president of quality and regulatory affairs since 2011. Prior to joining Sol-Gel, Ms. Levy-Hacham served as a scientific specialist and project manager at Biotechnology General Ltd., a fully integrated biopharmaceutical services private company from 2010 until 2011. From 2008 until 2010, Ms. Levy-Hacham served as the vice president chemistry, manufacturing and controls at HealOr Ltd., a private company engaging in the development of therapeutics for the treatment of various skin lesions and conditions. Ms. Levy-Hacham holds a Ph.D. in chemistry from The Technion - Israel Institute of Technology, Haifa, Israel.

Mr. Haim Bar-Simantov
Chief Technology Officer

Mr. Haim Barsimantov has served as our chief technology officer since September 2016. From 2000 until 2007, Mr. Barsimantov served as our plant manager. Since 2007 and until August 2016, Mr. Barsimantov served as our chief operating officer.

Ms. Karine Neimann
VP Projects and Planning & Chief Chemist

Ms. Karine Neimann has served as our vice president of projects and planning and chief chemist since September 2016. Since joining us in 2008 Ms. Neimann held various positions, including as chief chemist and laboratory manager. Ms. Neimann holds a Ph.D. in chemistry from The Hebrew University of Jerusalem, Israel.
 

Mr. Itzik Yosef
VP Operations

​Mr. Itzik Yosef has served as our vice president of operations since August 2016. Since joining us in 2010. Mr. Yosef held various positions including as head of operations. Mr. Yosef holds a Ph.D. in chemistry from The Hebrew University of Jerusalem, Israel.

Mr. Dov Zamir
VP Special Projects

​Mr. Dov Zamir has served as our vice president special projects since August 2016. Prior to joining us, Mr. Zamir lead the R&D group in Cima NanoTech Ltd., a private company developing sophisticated nanotechnology based coating formulations from 2007 until 2016. From 2004 to 2007, Mr. Zamir was VP of Pharma and Analytical R&D at Taro Pharmaceutical in Haifa, and for three years prior to that he managed its Analytical R&D lab. Mr. Zamir holds a Ph.D. in organic chemistry from Tel-Aviv University, Israel.

Prof. David Avnir
Co-Founder

David Avnir is a Professor at the Institute of Chemistry, The Hebrew University of Jerusalem, where he received all his academic qualifications and where he held, among others, the positions of Head of the School of Chemistry, Head of the Institute of Chemistry and Head of the Graduate School in Experimental Sciences. His current scientific activities include sol-gel organic hybrid materials and biomaterials, organically doped metals, and theoretical and experimental aspects of chirality and symmetry. Professor Avnir is one of Israel’s most cited chemists, and has received several awards including The Israel Chemical Society Prize (2011), placement on the Hebrew University's "Wall of Innovators'' (2012), and the Life Achievement Award of the International Sol-Gel Society (2013).